why choose us

First received: November 11, 2022

Clinical Trial: Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Healthy Subject

Study Type: Interventional


Official Title: A Randomized, Blinded, Placebo- and Positive-Controlled, Four-Period, Crossover-Design Thorough QT/QTc (TQT) Study to Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects

Brief Summary: This is A Randomized, Blinded, Placebo- and Positive-Controlled, Four-Period, Crossover-Design Thorough QT/QTc (TQT) Study to Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects

Read more